Hob Biotech Group Corp.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021
August 18, 2021 at 03:11 pm IST
Share
HOB Biotech Group Corp.,Ltd announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 147.542 million compared to CNY 78.852 million a year ago. Operating income was CNY 51.900 million compared to CNY 22.601 million a year ago. Net income was CNY 45.081 million compared to CNY 19.076 million a year ago. Basic earnings per share from continuing operations was CNY 0.746 compared to CNY 0.4 a year ago.
HOB Biotech Group Corp Ltd is a China-based company primarily engaged in the research and development, production and sales of in vitro diagnostic reagents. The Company provides two categories of products: allergy testing products and self-immune testing products. Its detection techniques include qualitative detection techniques such as enzyme-linked immunosorbent assay, and quantitative detection techniques such as enzyme-linked immunoassay capture method and nano-magnetic particle chemiluminescence method. The brands of allergy testing products include Oboke, Fubok, Shibok and Shibok Plus. The self-immune testing product brands include Norbok and Nabok. It is also engaged in the provision of reagent supporting testing instruments and others. The Company conducts its businesses in the domestic market.